The Use of Antiarrhythmic Drugs in Pediatrics
Clinical Audit on the Use of Antiarrhythmic Drugs in Pediatric Age Group
1 other identifier
observational
158
0 countries
N/A
Brief Summary
A study on the use of antiarrhythmic drugs in pediatric age group, in Assiut University Children's Hospital, a clinical audit
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2023
CompletedFirst Posted
Study publicly available on registry
February 22, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedFebruary 22, 2024
February 1, 2024
9 months
November 23, 2023
February 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Detect the rate of use of antiarrhythmic drugs in pediatrics and the different indications for them other than the control of arrhythmia.
A study on the use of antiarrhythmic drugs in pediatric age group, in Assiut University Children's Hospital and the different indications for them other than the control of arrhythmia
Baseline
Interventions
Antiarrhythmic drugs in pediatrics
Eligibility Criteria
All Patients with Arrhythmic cardiac diseases admitted at cardiology unit Assiut University Hospital aged from 1 month to 18 years.
You may qualify if:
- All Patients with Arrhythmic cardiac diseases admitted at cardiology unit Assiut University Hospital aged from 1 month to 18 years.
- All patient receiving antiarrhythmic drugs admitted to Assiut University Hospital for Children.
You may not qualify if:
- Any patient on drugs other than antiarrhythmics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 23, 2023
First Posted
February 22, 2024
Study Start
April 1, 2024
Primary Completion
December 31, 2024
Study Completion
March 31, 2025
Last Updated
February 22, 2024
Record last verified: 2024-02